Eur Rev Med Pharmacol Sci 2020; 24 (14): 7548-7548

DOI: 10.26355/eurrev_202007_22189

Suppression of adriamycin resistance in osteosarcoma by blocking Wnt/β-catenin signal pathway

B.-Q. Wu, Y. Cao, Z.-G. Bi

Department of Orthopedics, First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.


Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “Suppression of adriamycin resistance in osteosarcoma by blocking Wnt/β-catenin signal pathway, by B.-Q. Wu, Y. Cao, Z.-G. Bi, published in Eur Rev Med Pharmacol Sci 2017; 21 (14): 3185-3192–PMID: 28770967” has been withdrawn.

The Publisher apologizes for any inconvenience this may cause.

Suppression of adriamycin resistance in osteosarcoma by blocking Wnt/β-catenin signal pathway

Free PDF Download

To cite this article

B.-Q. Wu, Y. Cao, Z.-G. Bi
Suppression of adriamycin resistance in osteosarcoma by blocking Wnt/β-catenin signal pathway

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 14
Pages: 7548-7548
DOI: 10.26355/eurrev_202007_22189